The c-kit proto-oncogene encodes a transmembrane glycoprotein identical t o the receptor for the recently cloned stem cell factor (SCF). The present study examines constitutive synthesis of transcripts in primary acute myelogenous leukemia (AML) blasts and the effects of recombinant human tumor necrosis factor (TNF)-a on c-kit mRNA expression in these cells. The c-kit transcripts were detectable at low levels in 10 of 10 different AML samples investigated. TNF treatment of AML cells was associated with enhanced c-kit mRNA expression in all specimens. Nuclear run-on transcription assays indicated that the c-kit gene was transcriptionally active in all leukemias examined and the rate of transcription was unaffected by exposure t o TNF, suggesting posttranscriptional control mechanisms of c-kit mRNA accumulation. In the absence of TNF, the half-life of c-kit transcripts was 2 t o 3 hours, while in TNF-treated AML cells, c-kit half-life was found t o be 5 t o 9 hours. Inhibition of protein synthesis reduced TNF-induced e-kit mRNA expression by Northern blot analysis, but did not affect the rate of c-kit HE c-kit proto-oncogene, together with c-fms (encod-T ing the macrophage colony-stimulating factor [M-CSF] receptor), and the platelet-derived growth factor (PDGF) receptor, belongs to the growth factor receptor family.' The c-kit gene encodes a transmembrane receptor glycoprotein whose ligand has been recently identified to be the stem cell factor (SCF)? While SCF is produced by bone marrow stromal cells, c-kit is shown to be constitutively expressed by hematopoietic stem c e k 3 Mutations of those genes encoding the c-kit ligand or the SCF receptor c-kit result in congenital macrocytic anemia seen in Steel and W m i~e .~,~ The SCFlc-kit interaction is therefore believed to control steadystate hematopoiesis. Since blasts from patients with acute myelogenous leukemia (AML) have stem cell properties6 and have been shown to possess receptors for other hematopoietic growth factors including interleukin-3 (IL-3), granulocyte-macrophage (GM)-CSF, granulocyte (G)-CSF, and macrophage (M)-CSF,'-'O there is circumstantial evi-
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S. dence to assume that AML blasts may also express c-kit and thus may respond to SCF. Proliferative response of some AML cells to SCF has recently been demonstrated." TNF-a was shown to enhance IL-3 and GM-CSF-stimulated clonogenic growth of AML blasts,'* involving an upregulation of IL-3 and GM-CSF receptors on these cells. 13 We have hypothesized that TNF may similarly either upregulate c-kit expression by AML cells or enhance SCF release by the bone marrow stroma. Since no stroma layers are present in the culture systems describing TNFmediated enhancement of leukemia growth,'* we were in favor of the former hypothesis. The present studies have therefore examined expression of c-kit on the mRNA level in AML cells and have further examined the effects of TNF on synthesis of c-kit transcripts and protein by these cells. In addition, we have investigated the effect of both SCF and TNF-a, as well as a combination of both components, on clonogenic growth of primary AMLs. Our results demonstrate that all AML samples investigated disclosed low levels of c-kit mRNA that were significantly enhanced after exposure to TNF. Surface expression of SCF receptors was also upregulated in seven cases. Given these findings, mechanisms of action of TNF on c-kit mRNA expression and their functional consequences were also explored.
MATERIALS AND METHODS

Cells.
We selected 10 different peripheral blood samples of patients with de novo AML because of high leukemic blood counts (at least 50 x 103 leukemic blasts/wL blood) with relative blast counts always being greater than 95% by morphology. According to French-American-British (FAB) criteria,I4 six patients had M1 leukemia (cases 1 to 6), two had M2 leukemia (cases 7 to 8), and two had M4 leukemia (cases 9 and 10). Nine of these leukemias had previously been studied for expression of hematopoietic growth factor genes.15J6 Cases 3,7, and 9 were shown to synthesize transcripts for GM-CSF G-CSF mRNA expression was recorded For personal use only. on October 23, 2017. by guest www.bloodjournal.org From using the hexanucleotide primer technique.'* The filters were washed to a final stringency of 0.1X SSC (1X SSC is 0.15 mol/L sodium chloride, 0.015 mol/L sodium citrate, pH 7.0) at 65°C and exposed to Kodak X-Omat films (Eastman Kodak, Rochester, NY) with intensifying screens for 1 to 3 days. For nuclear run-on transcription assays, cells (108) were lysed in RSB (10 mmol/L Tris/HCl, 5 mmol/L KCI, 3 mmol/L MgC12) containing 0.5% Nonidet-P 40 (Sigma), and were washed once in ice-cold phosphatebuffered saline. Nuclei were incubated at 26°C in 15% glycerol, 70 mmol/L KC1, 2.5 mmol/L MgC12, 10 mmol/L EDTA, 4 mmol/L levels each of adenosine triphosphate (ATP), cytidine triphosphate (CTP), and guanosine triphosphate (GTP), 2 mmol/L uridine triphosphate (UTP), 0.5 mmol/L dithiothreitol, 60 U/mL RNasin (Boehringer Mannheim, Mannheim, Germany), in the presence of 100 pCi of [32P]UTP (3,000 Ci/mmol; Amersham), for 30 minutes. The mixture was digested with DNase I and proteinase K, extracted with trichloroacetic acid and phenol/chloroform, and precipitated in 70% ethanol before hybridization of 5 x 106 cpm/mL of hybridization buffer (50% formamide, 2X SSC, 1% sodium dodecyl sulfate, 5X Denhardt's solution [IX Denhardt's is 0.02% Ficoll, 0.02% bovine serum albumin (fraction V Sigma), 0.02% polyvinylpyrrolidone], 50 pg/mL tRNA). Filters contained 10 pg each of linearized plasmids immobilized on nitrocellulose (Schleicher and Schuell) after blotting with a slot-blot apparatus (Schleicher and Schuell). After hybridization at 42°C for 3 days, filters were rinsed in 2X SSC at 55T, 2X SSC containing 10 pg/mL RNase A at 37"C, and finally 0.5X SSC at 5YC, for 30 minutes each time, and were exposed to Kodak X-Omat films for 10 days. was performed. After repeated washings, cells were subjected to flow cytometry-analysis using FACStar (Beckton Dickinson, Heidelberg, Germany).
Clonogenic leukemia growth was assessed in a double-layer agar colony assay. To this end, freshly prepared AML blasts were resuspended in 0.3% agar (Difco, Detroit, MI) in Iscove's modified Dulbecco's minimum essential medium (IMD-
FACS-analysis.
Clonogenic assays. MEM, GIBCO) in the presence or absence of SCF (100 ng/mL) and/or TNF-a (25 ng/mL), layered on top of 0.5% agar, and cultured for 6 to 8 days (37"C, 7% C02) in 24-well plates (Falcon, Oxnard, CA) at 105 cells per well. After the culture period, agar overlayers were removed from underlayers by agitation, dried onto glass slides, fixed in methanol, and stained with acidic hematoxylin (Sigma). Colonies with greater than 20 blasts were enumerated by microscopy.
RESULTS
Northern blot analysis of total cytoplasmic RNA obtained from 10 different primary AML samples revealed specific signals of 5 kb in size upon probing with the human c-kit cDNA (Fig 1) . HEL cells served as the positive control and ACHN cells as negative control. TNF-a treatment (25 ng/mL) of these cells was associated with an increase in c-kit transcript levels in all leukemias (Fig 2) . Time course experiments, not shown here, indicated that the increase of c-kit transcript levels on TNF treatment started at 6 hours, reaching maximal levels at 24 hours, and were undiminished at 48 hours. Run-on transcription assays were performed to determine relative rates of c-kit transcription in nuclei isolated from untreated or TNF-treated AML cells. Fig 3, the c-kit gene was transcriptionally active in untreated leukemia cells, as was expected from the data obtained by mRNA hybridization. However, following exposure to TNF-a for 6 hours there was no detectable increase in the rate of c-kit transcription and no change of the decrease in actin transcript levels and no loss of cell viability (trypan blue dye exclusion) over that time period. Transcripts were quantitated by densitometric scanning of the autoradiographs and c-kir mRNA was normalized for actin mRNA using multiple exposures of the blots.
As shown in
As shown in Table 1 , the calculated half-life of c-kir transcripts in medium-treated cells ranged from 2 to 3
hours, while c-kir half-life increased to 5 to 9 hours following TNF treatment. To show whether c-kir mRNA stability was affected by inhibition of protein synthesis, TNF-treated cells (18 hours; 25 ng/mL) were exposed to 5 lg/mL cyclohexemide (CHX; Sigma) for 3 hours before act-D (5 pg/mL) was added. Again, c-kir mRNA levels progressively declined, while therc was no detectable effect on the levels of actin mRNA under these experimental conditions. The half-life in the CHX-treated cells was 2 to 4 hours, suggesting that stabilization of c&r mRNA by TNF required de novo protein synthesis (Table 2 ). To exclude transcription of @-actin (Fig 3) , while the rate of GM-CSF transcription increased. These results suggest that the increases in c&r mRNA levels on TNF exposure occurred as the result of posttranscriptional mechanisms. Next, studies on the stability of c&r mRNA were performed. To this end, AML cells were treated with medium alone orwith TNF (25 ng/mL) for 18 hours, 
that this effect was due to degradation of c-kit mRNA by ribosome-associated RNAses, similar experiments were performed with the protein synthesis inhibitors anisomycin and puromycin (200 pg/mL; Sigma), both effective inhibitors of translation. Again, we observed a reduction of c-kit mRNA halflife ranging from 2 to 4 hours as compared with cells treated with TNF-a only (not shown).
To further study the effect of CHX on c-kit mRNA levels, AML cells were treated with TNF (25 ng/mL) for 15 hours and exposed to TNF and CHX (5 pg/mL) for additional 6 hours. AS shown in Fig 4A, CHX decreased transcript levels of c-kit mRNA (but not of actin mRNA) by approximately 60% (laser densitometric analysis) as compared with cells that had received TNF during the last 6 hours of culture only.
To further confirm that the TNF-induced increase of c-kit transcripts required de novo protein synthesis, AML cells were treated for 1 hour with increasing concentrations of CHX (0.1 to 0.5 pg/mL) before TNF (25 ng/mL) was added for additional 24 hours. In control experiments, CHX treatment was replaced by treatment with medium only. As shown in Fig 4B, concentrations of CHX as low as 0.25 pg/mL inhibited c-kit mRNA levels. To determine whether exposure of CHX and TNF affected the transcriptional rate of the c-kit gene in AML cells, nuclear run-on experiments were performed. Treatment of AML cells with TNF (25 ng/mL) for 18 hours followed by exposure to CHX (5 pg/mL) had no effect on c-kit gene transcription compared with cells that were treated with TNF or medium only. Similarly, treatment of cells with CHX (0.5 pg/mL) for 1 hour before addition of TNF (25 ng/mL) for an additional 24 hours had also no effect on c-kit transcription (not shown).
We next examined the effect of TNF-a on c-kit protein expression. To this end, primary AMLs were cultured with or without TNF-a (25 ng/mL) for 60 hours and expression of the SCF-receptor was analyzed by flow cytometry. As shown in Fig 5, seven samples constitutively displayed surface expression of the SCF-receptor. Exposure of AML cells to TNF-a over a 60-hour period was associated with upregulation of SCF surface binding sites in all cases investigated. It has recently been shown that the mechanism of c-fins regulation in myeloid leukemia is similar to the one described here for c-kit, but that induction of differentiation of the leukemic cell population is required for c-fms expression. 21 The potential of TNF to induce a differentiation-associated phenotype of leukemia cells while enhancing c-kit levels was therefore investigated by flow cytometry analysis of the AML samples in suspension culture using a panel of myeloid/monocytic differentiation antigens. However, there was no evidence to suggest that exposure of AML cells to TNF was associated with induction of differentiation (not shown). We next examined the proliferative response of AMLs to exogenous SCF and TNF. As shown in Fig 6, exogenous SCF stimulated the clonogenic growth of all AMLs investigated, while TNF had no effect. However, a combined treatment of AMLs with SCF and TNF-a resulted in tional rate of the c-kit gene in the presence or absence of TNF. Taken together, these data indicate that TNF treatment of AML cells leads to upregulation of synthesis of c-kit transcripts. The finding that the c-kit transcript is stabilized by a labile protein suggests that TNF induces the synthesis of this protein and thereby the increase in c-kit mRNA levels. Our data are in accord with recent reports demonstrating upregulation of cytokine receptor mRNA through posttranscriptional mechanisms, eg, by deprivation of factordependent cell-lines from IL-3, GM-CSF, or erythropoietin.24,25 Taken together, these findings indicate that hematopoietic growth factor receptors might be transmodulated through modulation of the stability of their respective mRNAs. However, in addition to modulation of the SCF receptor gene expression, translational and posttranslational control mechanisms might still interfere with transmodulation of the SCF receptor by TNF-a. These mechanisms are likely to be responsible for the discrepancy between the c-kit mRNA increase and the unchanged SCF receptor surface expression as seen in AML-9.
It has previously been shown that TNF supports clonogenic growth of AML cells in the presence of exogenous or endogenously produced CSFs. Similarly, synergy of the c-kit ligand (ie, the SCF) with CSFs enhanced the capacity of AML cells to self-renew.1*,22 In this context, our finding that AMLs synthesize c-kit transcripts is of interest. Enhancement of c-kit transcript levels after exposure to TNF is associated with synergistic growth promotion and might explain the in vitro stimulatory activity of TNF on AML growth, when a source SCF is present in culture. Further work needs to be done to address the specific role of TNF as inducing agent for c-kit expression. In preliminary experiments, we failed to show any effect of other mesenchymal cell-derived factors on c-kit mRNA levels in AML cells such as IL-6, GM-CSF, and M-CSF. Since paracrine loops between AML blasts and bone marrow stroma cells established by upregulated expression of hematopoietic growth factors, growth factor-inducing factors and their receptors, are shown to be used by leukemic cells to escape their growth restriction, the biological consequence of the studies reported here may be to suggest a new paracrinism involving mesenchymal cell-derived TNF and SCF receptor expression by AML cells. In addition, our findings also indicate that SCF itself can stimulate clonogenic growth of AML blasts. However, it still remains to be elucidated whether this reflects a true SCF response or is mediated by synergism of SCF with GM-CSF or G-CSF endogenously produced by AML blasts.
